Max Heckler

9PUBLICATIONS
27CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Emergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 07, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity.

Katherine S Ventre, Kevin Roehle, Elisa Bello

|Sep 21, 2021
Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancreas SURVIVAL).

Max Heckler, Ulla Klaiber, Felix J Hüttner

|Jul 22, 2021
Type 2 immunity is maintained during cancer-associated adipose tissue wasting.

Patrick J Lenehan, Assunta Cirella, Amiko M Uchida

|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.

Kevin Roehle, Li Qiang, Katherine S Ventre

|Sep 10, 2020
Severe acute pancreatitis: surgical indications and treatment.

Max Heckler, Thilo Hackert, Kai Hu

|Aug 28, 2019
Meta-analysis of recurrence pattern after resection for pancreatic cancer.

M Tanaka, A L Mihaljevic, P Probst

Pageof 2

Frequent Collaborators

4 joint publications

Thilo Hackert

2 joint publications

M Tanaka

2 joint publications

P Probst

2 joint publications

U Klaiber